40916-73-2

Basic information

• Product Name: 1-Propanol, 2-(methylamino)-, (S)-
• CAS NO: 40916-73-2
• Molecular Formula: C4H11NO
• Molecular Weight: 89.1374
• Mol File: 40916-73-2.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 1-Propanol, 2-(methylamino)-, (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Propanol, 2-(methylamino)-, (S)-(40916-73-2)
• EPA Substance Registry System: 1-Propanol, 2-(methylamino)-, (S)-(40916-73-2)

Safety Data

• Hazardous Substances Data: 40916-73-2(Hazardous Substances Data)

Usage

Chemical group

Alcohols

Chirality

Chiral molecule with (S)-enantiomer having the chiral center

Usage

Organic synthesis, solvent, pharmaceuticals and agrochemicals production, surfactant, personal care products manufacturing

Applications

Wide range due to unique chemical properties and versatility

Upstream product

• 5893-10-7 (S)-2-formamidopropanoic acid 
• 35023-55-3 N-methyl-L-alanine methyl ester 
• 32221-83-3 (S)-N-formylalanine methyl ester 
• 3913-67-5 N-methylalanine 
• 34101-08-1 N-ethylthiothioxomethyl-L-alanine 

Downstream Products

• 95421-91-3 (S)-AlaNOP 
• 573701-30-1 (2S)-2-[benzyl(methyl)amino]propan-1-ol 

Relevant articles and documents

3,3-DISUBSTITUTED-1-HYDROXYTRIAZ-1-ENE 2-OXIDES AND WOUND-HEALING COMPOSITIONS USING THEM

Esters, carbonates and imides of 3,3-disubstituted-1-hydroxytriaz-1-ene 2-oxides of the formula I are disclosed. The compounds release nitric oxide (NO) under physiologic conditions, and pharmaceutical compositions containing them are useful to aid in wound healing.

2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS

The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction

The second-generation synthesis of 3′-hydroxypacidamycin D (2) has been accomplished via an Ugi-four component reaction at a late stage of the synthesis. This approach provided ready access to a range of analogues including diastereomers of the diaminobut